IRIS
MALERBA, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.328
EU - Europa 5.312
AS - Asia 3.918
SA - Sud America 794
Continente sconosciuto - Info sul continente non disponibili 277
AF - Africa 125
OC - Oceania 6
Totale 15.760
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.158
RU - Federazione Russa 1.466
SG - Singapore 1.201
IE - Irlanda 1.099
CN - Cina 888
HK - Hong Kong 676
IT - Italia 639
BR - Brasile 606
DE - Germania 585
VN - Vietnam 544
SE - Svezia 397
UA - Ucraina 393
FR - Francia 339
BD - Bangladesh 145
GB - Regno Unito 129
IN - India 101
KR - Corea 83
AR - Argentina 75
CA - Canada 75
ID - Indonesia 63
FI - Finlandia 57
MX - Messico 54
NL - Olanda 47
BJ - Benin 46
EC - Ecuador 34
PL - Polonia 34
ZA - Sudafrica 31
JP - Giappone 29
IQ - Iraq 28
PK - Pakistan 25
CO - Colombia 23
SA - Arabia Saudita 23
AT - Austria 21
BE - Belgio 20
ES - Italia 20
TR - Turchia 18
CL - Cile 15
VE - Venezuela 15
LT - Lituania 12
PH - Filippine 12
CZ - Repubblica Ceca 11
EU - Europa 11
UZ - Uzbekistan 10
DZ - Algeria 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
IR - Iran 8
JM - Giamaica 8
MA - Marocco 8
PY - Paraguay 8
CH - Svizzera 7
EG - Egitto 6
PE - Perù 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AU - Australia 5
CR - Costa Rica 5
JO - Giordania 5
KE - Kenya 5
MY - Malesia 5
NP - Nepal 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
TN - Tunisia 5
TW - Taiwan 5
AL - Albania 4
BO - Bolivia 4
EE - Estonia 4
ET - Etiopia 4
PA - Panama 4
SV - El Salvador 4
TH - Thailandia 4
DO - Repubblica Dominicana 3
GT - Guatemala 3
KG - Kirghizistan 3
LV - Lettonia 3
QA - Qatar 3
AM - Armenia 2
AO - Angola 2
BS - Bahamas 2
GE - Georgia 2
GR - Grecia 2
KW - Kuwait 2
KZ - Kazakistan 2
MN - Mongolia 2
NO - Norvegia 2
OM - Oman 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
GM - Gambi 1
GP - Guadalupe 1
GY - Guiana 1
Totale 15.477
Salva come PNG Salva come JPEG
Città #
Dublin 1.092
Jacksonville 755
Hong Kong 669
San Jose 504
Singapore 450
Ashburn 394
Dearborn 366
Council Bluffs 321
Beijing 262
Moscow 164
Ho Chi Minh City 158
Los Angeles 151
Lauterbourg 150
Hanoi 143
Princeton 143
Lawrence 142
Wilmington 142
Columbus 141
San Mateo 121
Ann Arbor 94
Santa Clara 90
Seoul 78
Buffalo 76
New York 74
Chandler 71
Milan 68
São Paulo 64
Orem 53
Novara 49
Redondo Beach 47
Cotonou 46
Houston 45
Rome 40
Dallas 39
Munich 39
Piemonte 39
St Louis 39
Helsinki 38
Seattle 37
Turin 31
Mexico City 30
Chennai 27
Guangzhou 27
Warsaw 26
Atlanta 24
Haiphong 24
Jakarta 24
Denver 23
Nanjing 23
Nuremberg 23
Rio de Janeiro 23
Da Nang 21
Hefei 21
Torino 21
Frankfurt am Main 20
Stockholm 20
Tokyo 20
Brussels 19
Dong Ket 18
London 18
Norwalk 18
Tianjin 18
Montreal 17
Toronto 17
Woodbridge 17
Boardman 16
Medina 16
Shanghai 16
Viggiano 16
Brooklyn 15
Johannesburg 15
Quito 15
San Francisco 15
Andover 14
Falkenstein 14
Kunming 14
Manchester 14
Philadelphia 14
Turku 14
Chicago 13
Amsterdam 12
Assago 12
Hangzhou 12
Mumbai 12
Nanchang 12
Poplar 12
Belo Horizonte 11
Boston 11
Thái Bình 11
Berlin 10
Brno 10
Palermo 10
Quetta 10
Saint Louis 10
Shenzhen 10
Bremen 9
Curitiba 9
Dhaka 9
Jinan 9
Mauá 9
Totale 8.395
Salva come PNG Salva come JPEG
Nome #
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 341
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 263
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 204
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 193
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence 192
Change over time of COVID-19 hospital presentation in Northern Italy 169
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 166
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 163
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside ICU 162
Ambroxol in the 21st century: pharmacological and clinical update 159
Role of beta-blockers in patients with COPD: current perspective. 158
Sleep apnea and psoriasis: A cohort study 154
DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases 153
Identification of Key Phospholipids That Bind and Activate Atypical PKCs 149
Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction 148
[Alpha 1-antitrypsin deficiency: the Brescia clinical study]. FT Il deficit di alpha 1-antitripsina: lo studio clinico di Brescia. 143
Interrelationship among Obstructive Sleep Apnea,Renal Function and Survival: A Cohort Study 143
Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome? 131
Analysis of mitochondrial DNA alteration in new phenotype ACOS 126
Association of FEF25-75% Impairment with Bronchial Hyperresponsiveness and Airway Inflammation in Subjects with Asthma-Like Symptoms 124
Circulating Peptidome Is Strongly Altered in COVID-19 Patients 119
Age-Related Increase of Airway Neutrophils in Older Healthy Nonsmoking Subjects 119
Acute respiratory distress following intravenous injection of trichloroethylene 117
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons 115
ACUTE VENTILATORY AND GAS-EXCHANGE EFFECTS OF A NEW BETA-2 AGONIST, BROXATEROL, IN ASTHMATICS 114
EXHALED NITRIC OXIDE AS A MARKER OF LUNG INVOLVEMENT IN CROHN'S DISEASE 113
A randomized trial of cefepime and ceftazidime for the treatment of community-acquired pneumonia 113
Exosomes in chronic respiratory diseases 111
Dupilumab and tezepelumab in severe refractory asthma: new opportunities 110
[Pharmacologic control of breathing]. FT Controllo farmacologico della ventilazione. 110
Aging and induced-sputum cells 110
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases 109
Late Breaking Abstract- New imaging approach to evaluate the in vivo administration of nanostructured mycophenolic acid in a preclinical model of SSC-ILD 108
Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: A model to study tuberculosis immunity 107
DOXAZOSIN IN THE TREATMENT OF HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 102
Airway hyperresponsiveness in a large group of subjects with alpha(1)-antitrypsin deficiency: a cross-sectional controlled study 102
Biological pathways and mechanisms linking COPD and cardiovascular disease 101
Comorbid insomnia and obstructive sleep apnea (Comisa): Current concepts of patient management 101
Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients. 101
[Severe alpha 1-antitrypsin deficiency: cross sectional clinical study]. FT Grave deficit di alpha 1-antitripsina: studio clinico trasversale. 101
Determinants of smoking status in a sample of outpatients afferent to a tertiary referral hospital 101
Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 100
Exhaled Nitric Oxide as a Biomarker in COPD and Related Comorbidities 100
Ineffectiveness of intravenous beta(2)-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction 98
Identification of IL-17F/frequent exacerbator endotype in asthma 97
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions 96
Long term adjustment of stable asthma treatment with fractional exhaled nitric oxide and sputum eosinophils 96
[Infective pneumopathies in old age]. FT Pneumopatie infettive in eta geriatrica. 95
Folic acid in general medicine and dermatology 95
Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement 95
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 93
[General practitioner and respiratory medicine specialist. A survey on the management of the asthmatic patient]. FT Indagine conoscitiva sul rapporto tra medico di medicina generale e specialista in medicina respiratoria nella gestione clinica del paziente asmatico. 92
[Changes in the heart rhythm and slow-release beta-2 agonist therapy (peroral) in asthmatic patients. A Holter study]. Alterazioni del ritmo cardiaco e terapia beta-2-agonista a lento rilascio (per via orale) in pazienti asmatici. Studio Holter. 91
Glucocorticoid-induced osteoporosis in asthma and respiratory diseases 91
Dupilumab for the treatment of asthma 90
Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma 90
Biological investigations | [Indagini biologiche] 90
Biological investigations in pulmonology [Indagini biologiche in pneumologia] 89
[Tracheal stenosis due to metastatic adenopathic compression from breast carcinoma]. FT Stenosi tracheale per compressione adenopatica metastatica da carcinoma della mammella. 88
THE POTENTIAL THERAPEUTIC ROLE OF POTASSIUM CHANNEL MODULATORS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE 88
Triple inhaled therapy for chronic obstructive pulmonary disease 88
Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients. 88
Bronchial Progenitor Cells in Obstructive and Neoplastic Lung Disease: A Pilot Study 87
Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease. 87
Psoriasis and risk of myocardial infarction 87
Vilanterol trifenatate for the treatment of COPD. 87
Non-Invasive Biomarkers of Lung Inflammation in Smoking Subjects 87
The Combined Impact of Exhaled Nitric Oxide and Sputum Eosinophils Monitoring in Asthma Treatment: A Prospective Cohort Study 87
Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma. 87
SUB-CLINICAL LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN EARLY STAGE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 87
Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects 86
[Respiratory effects of antihypertensive agents acting on alpha adrenergic receptors]. Effetti respiratori dei farmaci antiipertensivi che agiscono sui recettori alfa adrenergici. 86
Potential role of diacylglycerol kinases in immune-mediated diseases 86
Prolonged higher dose methylprednisoloneversusconventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 85
COVID-19 infection is a significant risk factor for death in patients presenting with acute cholecystitis: a secondary analysis of the ChoCO-W cohort study 85
Potential role of hematological parameters in patients with chronic obstructive pulmonary disease: current point of view 85
UPPER EXTREMITY DEEP VEIN THROMBOSIS AS AN UNCOMMON COMPLICATION OF PACEMAKER IMPLANTATION: A CASE REPORT 84
Micellar electrokinetic chromatography determination of desmosine in urine from patients with chronic lung disease. 84
PNEUMOLOGY 84
[Rhinitis and asthma]. FT Rinite e asma. 84
Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD 83
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes 83
Usefulness of Exhaled Nitric Oxide and Sputum Eosinophils in the Long-term Control of Eosinophilic Asthma 82
Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment 82
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease 82
Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease 81
Cardiac arrhythmia monitoring during bronchial provocation test with methacholine 81
SEVERE INTRAVASCULAR HAEMOLYSIS AS DELAYED MANIFESTATION OF PERIVALVULAR LEAK IN PATIENTS WITH MITRAL VALVE REPLACEMENT: A REPORT OF TWO CASES 81
Sleep Deprivation, Immune Suppression and SARS-CoV-2 Infection 80
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus‐associated disease in breakthrough infections in adults ≥60 years of age 80
Investigational prostaglandin D2 receptor antagonists for airway inflammation. 80
Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma 79
Cardiorespiratory intermediate intensive unit: heart-lung interactions. 79
EXHALED NITRIC OXIDE IS RELATED TO BRONCHIAL EOSINOPHILIA AND AIRWAY HYPERRESPONSIVENESS TO BRADYKININ IN ALLERGEN-INDUCED ASTHMA EXACERBATION 79
Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. 78
Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD 78
Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects 78
Therapeutic potential for novel ultra long-acting beta(2)-agonists in the management of COPD: biological and pharmacological aspects 78
Effect of two beta(2)-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis 78
Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects. 77
Totale 10.819
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.793
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022940 0 13 142 93 63 21 53 27 98 19 124 287
2022/20231.707 156 89 61 20 31 77 61 70 1.049 13 60 20
2023/2024707 43 47 32 25 130 12 81 20 13 7 150 147
2024/20251.863 23 15 42 28 36 114 181 148 530 265 102 379
2025/20266.894 247 230 553 1.093 584 482 893 1.039 523 606 373 271
2026/20271.024 435 589 0 0 0 0 0 0 0 0 0 0
Totale 15.760